Rein Therapeutics, Inc. Common Stock (RNTX) is a publicly traded Healthcare sector company. As of November 16, 2026, RNTX trades at $0.55 with a market cap of $47.63M and a P/E ratio of -0.40. RNTX moved -0.02% today. Year to date, RNTX is -55.83%; over the trailing twelve months it is -59.10%. Its 52-week range spans $0.50 to $2.40. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces RNTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
RNTX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RNTX recently traded at $0.55. Market cap is $47.63M. P/E ratio is -0.40. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $0.55 |
| Market Cap | $47.63M |
| P/E Ratio |
| -0.40 |
| EPS | $-1.96 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $2.40 |
|---|
| 52-Week Low | $0.50 |
|---|
| Volume | 5.41K |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $0 |
|---|
| Net Income | $-49.87M |
|---|
| Gross Margin | 0.00% |
|---|
2 analysts cover RNTX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $6.00.